FCGR2A rs1801274 polymorphism is associated with response to natalizumab in multiple sclerosis patients
Arquivos de Neuro-Psiquiatria · 01.08.2024 · 82 (S 01 S 01) · S1-S52
DOI: 10.1055/s-0044-1789375 ↗Kurz gefasst
Fachartikel in der Zeitschrift Arquivos de Neuro-Psiquiatria, erschienen am 01.08.2024. Verfasst von Matheus D. de Matos und 10 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Address for correspondence: João Gabriel Dib Farinhas (email: jgabrieldib@gmail.com).
Zitieren
APA
Matos, M. D. D., Cardoso, R. C., Duarte, L. A., Guimenez, B. D., Pavani, G. K., Fernandez, K. A., Farinhas, J. G. D., Schmidt, F. D. R., Montes, G. C., Alves-Leon, S. V., & Fontes-Dantas, F. L. (2024). FCGR2A rs1801274 polymorphism is associated with response to natalizumab in multiple sclerosis patients. Arquivos de Neuro-Psiquiatria, 82(S 01 S 01), S1-S52. https://doi.org/10.1055/s-0044-1789375
Vancouver
Matos MDD, Cardoso RC, Duarte LA, Guimenez BD, Pavani GK, Fernandez KA, et al. FCGR2A rs1801274 polymorphism is associated with response to natalizumab in multiple sclerosis patients. Arquivos de Neuro-Psiquiatria. 2024;82(S 01 S 01):S1-S52. doi:10.1055/s-0044-1789375
BibTeX
@article{Matos2024,
author = {Matos, Matheus D. de and Cardoso, Rafaella C. and Duarte, Larissa A. and Guimenez, Barbara D. and Pavani, Giovanni K. and Fernandez, Kamilla A. and Farinhas, João Gabriel Dib and Schmidt, Felipe da R. and Montes, Guillherme C. and Alves-Leon, Soniza V. and Fontes-Dantas, Fabricia L.},
title = {FCGR2A rs1801274 polymorphism is associated with response to natalizumab in multiple sclerosis patients},
journal = {Arquivos de Neuro-Psiquiatria},
year = {2024},
volume = {82},
number = {S 01 S 01},
pages = {S1--S52},
doi = {10.1055/s-0044-1789375}
}
EUVIMED